Loading company…
Develops radiopharmaceuticals and radionuclide coupling technology for cancer diagnosis and treatment.
Saihe Biotechnology researches radiopharmaceuticals and radionuclide coupling technologies for cancer diagnosis and treatment. The company is based in Hangzhou, China, and was founded in 2024. In March 2026, it closed Angel+ funding led by FIRHealth Capital, with Longtai Investment participating.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in